Systemic Mastocytosis Hub
Equity in Diagnostic Testing Overview
Systemic mastocytosis (SM) is a rare disease in which diagnostic testing disparities present itself in underdiagnosis*(**). SM is challenging to identify because of low prevalence, therefore comprehensive testing is crucial for optimal outcomes.
Key SM tests include:
Blood tests
Urine tests
Bone marrow biopsies
Skin biopsies
X-rays
Ultrasounds
Bone scans
CT scans
Genetic testing such as next-generation sequencing that can identify specific mutations that respond better to certain therapies
Programs
Resources
Designed with health equity in mind, HubKits are packed with expert knowledge that give you the information necessary to confidently share in decision-making with their health care providers. Download a HubKit to equip yourself for an equitable conversation with your care team.
Have feedback for us?
Are there topics you'd like us to cover? How can we better help you?.
Sources
*Systemic Mastocytosis. Mayo Clinic website. Accessed March 16, 2023. https://www.mayoclinic.org/diseases-conditions/systemic-mastocytosis/diagnosis-treatment/drc-20450478
**Daniel DeAngelo, Sa Wang. Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment. OncLive website. Accessed March 16,, 2023. https://www.onclive.com/view/advanced-systemic-mastocytosis-expert-insight-into-epidemiology-diagnosis-and-treatment